Category: Press Release
Reproductive Medicine Associates of New York Presents Ground Breaking Research at ASRM's 74th Annual Meeting
RMA of New York is using big data to improve IVF success rates and researching the declining sperm count in the United States.
October 9, 2018
Read More![Castle Connolly Recognizes Eight RMA of New York Physicians as 2018 "Top Doctors"]()
Castle Connolly Recognizes Eight RMA of New York Physicians as 2018 "Top Doctors"
RMA of New York physicians recognized as 2018 "Top Doctors" in Reproductive Endocrinology, Obstetrics and Gynecology, and Urologic treatment of infertility
February 13, 2018
Read More![Embryo Transfer following Screening, Freezing, and Thawing shown to be more successful than Fresh Transfer of Screened Embryos]()
Embryo Transfer following Screening, Freezing, and Thawing shown to be more successful than Fresh Transfer of Screened Embryos
Embryo Transfer following Screening, Freezing, and Thawing shown to be more successful than Fresh Transfer of Screened Embryos
November 9, 2017
Read More![Reproductive Medicine Associates of New York Delivers Breakthrough Research at 73rd ASRM Annual Meeting]()
Reproductive Medicine Associates of New York Delivers Breakthrough Research at 73rd ASRM Annual Meeting
Reproductive Medicine Associates of New York Delivers Breakthrough Research at 73rd ASRM Annual Meeting
November 9, 2017
Read More![Sema4 Appoints Fertility Expert Alan Copperman, MD, as Chief Medical Officer]()
Sema4 Appoints Fertility Expert Alan Copperman, MD, as Chief Medical Officer
Sema4, a health information company providing advanced genomic testing, today announced the appointment of Alan B. Copperman, MD, as Chief Medical Officer. Dr. Copperman is Director of the Division of Reproductive Endocrinology and Infertility and Vice Chairman of the Department of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai, and is Managing Partner at Reproductive Medicine Associates of New York.
October 6, 2017
Read More![Better Technology in Assisted Reproduction Translates to Bigger Babies: Reproductive Medicine Associates of New York Shared an Eleven-Year Study on Birthweight Outcomes in IVF at ASRM 2016]()
Better Technology in Assisted Reproduction Translates to Bigger Babies: Reproductive Medicine Associates of New York Shared an Eleven-Year Study on Birthweight Outcomes in IVF at ASRM 2016
Reproductive Medicine Associates of New York (RMA of New York), a premier Manhattan-based fertility center, revealed details of its analysis into the impact of technological advances in the field of in vitro fertilization (IVF) on the birthweight of babies conceived as a result of the treatment.
October 25, 2016
![Neither BMI nor the Diagnosis of PCOS Found to Impact the Likelihood of Having a Chromosomally Normal Embryo in IVF Patients using Comprehensive Chromosomal Screening]()
Neither BMI nor the Diagnosis of PCOS Found to Impact the Likelihood of Having a Chromosomally Normal Embryo in IVF Patients using Comprehensive Chromosomal Screening
Manhattan-based fertility center Reproductive Medicine Associates of New York (RMA of New York) revealed its latest research into the relationship between body mass index (BMI), in vitro fertilization (IVF), pregnancy outcomes and euploidy. The findings of RMA of New York's latest study were presented alongside 32 other scientific abstracts at the 2016 American Society for Reproductive Medicine (ASRM) conference in Salt Lake City, Utah which occurred October 15-19, 2016.
October 25, 2016
Read More![Reproductive Medicine Associates of New York Demonstrated that Chromosomally Normal Embryos Lead to Healthy Babies, Even if the Embryos are Given a Poor Grade Based on Morphology at ASRM 2016]()
Reproductive Medicine Associates of New York Demonstrated that Chromosomally Normal Embryos Lead to Healthy Babies, Even if the Embryos are Given a Poor Grade Based on Morphology at ASRM 2016
Reproductive Medicine Associates of New York (RMA of New York), a leading Manhattan-based fertility center, presented data from a retrospective cohort and case control study analyzing the relationship between the transfer of embryos deemed "poor quality" by morphological grading, and the potential impact on gestational age at delivery and infant birthweight.
October 24, 2016
Read More![Reproductive Medicine Associates of New York Unveils Encouraging Data on Aneuploidy Rates in Embryos of Patients Carrying BRCA Mutation at 2016 ASRM Conference]()
Reproductive Medicine Associates of New York Unveils Encouraging Data on Aneuploidy Rates in Embryos of Patients Carrying BRCA Mutation at 2016 ASRM Conference
Leading Manhattan-based fertility center Reproductive Medicine Associates of New York (RMA of New York), will present stimulating findings from a retrospective cohort study analyzing ovarian reserve and embryonic aneuploidy rates in BRCA 1 and 2 carriers as part of a set of 33 scientific abstracts at the 72nd annual meeting of the American Society of Reproductive Medicine (ASRM). The data concludes that although patients who carry the BRCA mutation are known to have an altered DNA repair mechanism, their embryos did not demonstrate increased rate of aneuploidy.
October 19, 2016
Read More![Reproductive Medicine Associates of New York Presents 33 Scientific Abstracts at 2016 ASRM Conference in Salt Lake City, Utah]()
Reproductive Medicine Associates of New York Presents 33 Scientific Abstracts at 2016 ASRM Conference in Salt Lake City, Utah
Reproductive Medicine Associates of New York (RMA of New York) a Manhattan-based fertility center, is presenting 33 scientific abstracts at this year's American Society for Reproductive Medicine (ASRM) conference in Salt Lake City, Utah. Infertility specialists, embryologists, researchers and other experts from RMA of New York will discuss the latest developments in clinical research findings the clinic has discovered in the field of reproductive science.
October 17, 2016
Read More